Tag:
GIST
Latest Headlines
Latest Headlines
AB soars on promising survival data from Phase II tumor study
Shares of Paris-based AB Science shot up yesterday after the drug developer reported strong efficacy results from a midstage study of its experimental drug for gastrointestinal tumors. The treatment,
